Banner
Watch on-demand

Viral vector digital symposium

#000
Overview
Overview
Speaker
Speaker
Overview
sciextext
text-left

Discover intuitive, innovative and informative analytical solutions for viral vector characterization to help ensure safe and effective drugs.

Overcome the challenges of developing viral vector vaccines and therapeutics. Hear from industry experts how they have reclaimed their time and broken through boundaries to realize the full potential of using viral vectors with LC-MS and CE solutions.

registerform
Watch now
https://forms.sciex.com/f/lp?campaign_id=7013w000002MOMUAA4&utm_term=G-%20viral%20vectors%20videos%20-%200424&primary_app=&market_vertical=Biopharma&sub_vertical=&utm_campaign=4.2%20cell%20and%20gene%20therapy%20workflow%20leadership&utm_source=SCIEX.com&solution=&utm_content=WOD&ty=https://sciex.com/Hidden/landing-pages/viral-vector-digital-symposium/thank-you-for-your-interest&show_mv=true
one-column
1200pixel
Speaker
Speakers

Application of CE for purity analysis in cell and gene therapy

Ryan Hylands / Luiza Chrojan
Senior Technical Specialist / Scientific Associate II, Analytical Sciences, Pharmaron Gene Therapy

Critical quality attributes for AAV analysis

Shilin Cheung
Senior Research Scientist, Phenomenex

Characterization of residual nucleic acids in cell culture-derived vaccines and therapeutics

Peter Holper
Staff Application Scientist, SCIEX

A new, versatile approach for high resolution full and empty AAV analysis

Jane Luo
Senior Scientist, SCIEX

COVID vaccine purity by SWATH LC-MS

Ejvind Mortz
COO and Co-Founder, Alphalyse